VotedBy VotedBy ⌕
Election Day · Tue, Nov 3See how your members of Congress voted →

H.R. 2343 · 119th Congress

John W. Walsh Alpha-1 Home Infusion Act of 2025

Key: what the circles and colors mean

Each circle is a bill. The ring fills as it moves through Congress:

IntroducedPassed one chamberPassed both chambersBecame law (gold)Resolution agreed to (full, dark)Failed or vetoed (gray)

Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.

Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.

Not yet voted on. This bill is still a proposal: it hasn't reached a floor vote, and its text can change in committee or on the floor before any vote.

MSR SalazarSponsor
61 cosponsors · 39 D, 22 R
HJD Johnson YKR Kim END Norton BOR Owens CPD Pingree DRR Rouzer CSR Smith PTD Tonko TKD Kennedy MLR Lawler NLR Langworthy RRD Ruiz MSD Sherrill ACD Craig TCD Carter WKD Keating TKR Kean JND Neguse JPD Panetta BWD Watson Coleman NMR Malliotakis RWR Weber JGD Gottheimer LMD McIver DMD Matsui JLD Larson JBD Bynum HCD Conaway GLD Latimer JRR Rutherford EVD Vindman DRD Ross DVR Valadao JVR Van Drew CMR Maloy ASR Smith RMR Mackenzie SMD McBride MFR Flood DBR Bacon SLD Lynch MKR Kennedy SED Elfreth LGD Gillen AGR Garbarino JRD Riley AMD McClain Delaney CMR Miller MTD Thompson JGD Garamendi MHR Haridopolos CDD Deluzio FWD Wilson DSD Soto GMD Meng DVR Van Orden BSD Schneider RTD Tlaib DWD Wasserman Schultz ABD Bera JJD Jackson

8 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.

This bill provides for Medicare coverage of treatment for alpha-1 antitrypsin (AAT) deficiency (a protein deficiency that raises the risk of lung and other diseases). Specifically, the bill provides for coverage of at-home augmentation therapy for beneficiaries with emphysema as a result of severe hereditary AAT deficiency.

What it does: CRS summary · Introduced in House · Mar 25, 2025

John W. Walsh Alpha-1 Home Infusion Act of 2025

This bill provides for Medicare coverage of treatment for alpha-1 antitrypsin (AAT) deficiency (a protein deficiency that raises the risk of lung and other diseases). Specifically, the bill provides for coverage of at-home augmentation therapy for beneficiaries with emphysema as a result of severe hereditary AAT deficiency. Treatment must be provided through qualified home infusion therapy suppliers; beneficiaries must be under the care of a physician, nurse practitioner, or physician assistant.

Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov

About this bill and sources

Official title: John W. Walsh Alpha-1 Home Infusion Act of 2025

Latest action (Mar 25, 2025): Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Policy area: Health · Origin: House · Introduced: Mar 25, 2025

Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)

No recorded floor vote found.